Publication:
Charles Bonnet Syndrome after Herpes Simplex Encephalitis

dc.authorscopusid55412732700
dc.authorscopusid19640001600
dc.authorscopusid6601981559
dc.authorscopusid6603156640
dc.contributor.authorAydin, Ö.F.
dc.contributor.authorInce, H.
dc.contributor.authorTaşdemir, H.A.
dc.contributor.authorÖzyürek, H.
dc.date.accessioned2020-06-21T14:27:52Z
dc.date.available2020-06-21T14:27:52Z
dc.date.issued2012
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Aydin] Ömer Faruk, Department of Pediatric Neurology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Ince] Hülya, Department of Pediatric Neurology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Taşdemir] Haydar Ali, Department of Pediatric Neurology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Özyürek] Hamit, Department of Pediatric Neurology, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractVisual impairment associated with Charles Bonnet syndrome is rarely reported in childhood. We describe a child who presented with visual hallucinations and postinfectious bilateral retrobulbar optic neuritis. The patient had undergone acyclovir therapy for 3 weeks because of herpes encephalitis. Four days after therapy was completed, he experienced visual impairment in both eyes. He manifested a bilateral decrease in visual acuity, with normal funduscopic findings. The patient experienced visual hallucinations for about 1 week, and then experienced total loss of vision. During his hallucinations, the patient did not exhibit behavioral changes or cognitive impairment. The visual hallucinations included unfamiliar children hiding under his bed, and he spoke to someone whom he did not know. Magnetic resonance imaging indicated bilateral optic nerve hyperintensity on T <inf>2</inf>-weighted and contrast-enhanced images. The patient received corticosteroid therapy for his retrobulbar optic neuritis, and his vision returned to normal after 1 month. Although rare, visual impairment can be associated with complex visual hallucinations indicative of Charles Bonnet syndrome. © 2012 Elsevier Inc. All rights reserved.en_US
dc.identifier.doi10.1016/j.pediatrneurol.2012.02.010
dc.identifier.endpage252en_US
dc.identifier.isbn9781613247266
dc.identifier.issn0887-8994
dc.identifier.issn1873-5150
dc.identifier.issue4en_US
dc.identifier.pmid22490773
dc.identifier.scopus2-s2.0-84859522022
dc.identifier.scopusqualityQ2
dc.identifier.startpage250en_US
dc.identifier.urihttps://doi.org/10.1016/j.pediatrneurol.2012.02.010
dc.identifier.volume46en_US
dc.identifier.wosWOS:000303222000010
dc.identifier.wosqualityQ2
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofPediatric Neurologyen_US
dc.relation.journalPediatric Neurologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleCharles Bonnet Syndrome after Herpes Simplex Encephalitisen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files